Across social media, castor oil is frequently promoted as a natural solution for thinning hair, sparse eyebrows, and slow hair growth. Users massage the thick oil directly into th ...
Galderma announced an agreement to acquire ZO Skin Health for an enterprise value of $1.5 billion, a move designed to expand ...
Christopher Bunick, MD, PhD, reviews data on investigational atopic dermatitis agents presented at EADV 2026 and biomarker ...
Gelfand described psoriasis as an inflammatory metabolic disease. Among inflammatory diseases of medicine, he said psoriasis has by far the closest association with obesity. Obesity makes psoriasis ...
A methodical up-titration schedule and clear expectations help patients reach the point where advanced therapy is appropriate. With no approved CIndU medication, clinicians are extrapolating from CSU.
Remibrutinib is approved for chronic spontaneous urticaria (CSU) and most recently, symptomatic dermographism, with the label ...
In "Recognizing EPP: Diagnostic Red Flags, Psychosocial Burden, and Confirmatory Workup," Dr. Bonkovsky turns to what should ...
An analysis of 633 skincare brands found gaps in evidence, safety information, and claim support, raising questions about ...
Cosibelimab (Unloxcyt; Sun Pharma), a PD-L1 inhibitor, is also approved for locally advanced and metastatic cutaneous ...
In "Case 2: Escalating Therapy After Biologic Failure in HS," the panel shifts to the series' second patient case.
A patient with 45 percent hair loss and a wedding in six months illustrates why psychosocial burden can reclassify disease ...
Christophe Piketty discusses 3-year ARCADIA data demonstrating sustained efficacy and long-term safety of nemolizumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results